INGN — Inogen Inc

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1294133 ·
Last close
$5.50
Market Cap
$145.96M
52W High
$7.08
52W Low
$5.50
ADV30
241,736
Next earnings
2026-11-05
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026
Mar 2026 85,109,000 37,863,000 -9,336,000 -8,324,000 285,926,000 93,112,000 103,020,000
Dec 2025 81,721,000 35,236,000 -9,306,000 -7,127,000 298,625,000 103,729,000 106,394,000
Sep 2025 92,390,000 41,316,000 -7,116,000 -5,294,000 307,009,000 106,476,000 109,834,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,111,000
Investing CF
$-26,146,000
Financing CF
$-1,892,000
CapEx
$-9,126,000
Dividends Paid
Buybacks
$-1,874,000
EPS Diluted TTM
$-0.90
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-183,908,000
Inventory
$24,992,000
Receivables
$41,874,000
ST Investments
$17,059,000
EBIT TTM
$-31,887,000
Pretax Income TTM
$-25,606,000
Interest Exp TTM
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$354,304,000
EBITDA
$-8,085,000
Free Cash Flow
$-1,768,500
Enterprise Value
$59,135,072
Total Cash
$105,539,000
Total Debt
$15,794,000
Shares Out
26,538,337
Trailing EPS
$-0.91
Book Value
$6.54
ROE
-13.1%
ROA
-5.8%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 348,668,000 -30,207,000 -22,747,000 298,625,000 106,394,000 -11,216,000
Dec 2024 335,705,000 -42,516,000 -35,888,000 296,185,000 122,325,000 5,914,000
Dec 2023 315,660,000 -76,492,000 -102,449,000 326,194,000 121,382,000 -3,234,000
Dec 2022 377,241,000 -33,082,000 -83,772,000 405,041,000 107,635,000 -37,532,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.16

Peers — same industry

TickerNameMarket CapLastDaily %
KRMD KORU Medical Systems, Inc. $148.67M $3.22
STXS Stereotaxis, Inc. $142.29M $1.42
EBRCZ EBR Systems, Inc. $158.20M $0.21
NYXH Nyxoah SA $162.12M $1.62
APYX Apyx Medical Corp $129.74M $3.08

News headlines (Yahoo Finance, 1h cache)

Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
2026-08-21 15:46 · Yahoo
Inogen (INGN) Q2 2026 Earnings Call Transcript
2026-08-14 15:03 · Yahoo
Inogen Inc (INGN) (Q2 2026) Earnings Call Highlights: Strong International Growth and New ...
2026-08-07 05:04 · Yahoo
Inogen Q2 Earnings Call Highlights
2026-08-07 03:03 · Yahoo
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates
2026-08-06 23:10 · Yahoo
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-07-16 12:30 · Yahoo
How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions
2026-05-11 00:18 · Yahoo
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves
2026-05-08 14:41 · Yahoo
Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
2026-08-19 14:08 · Yahoo
Inogen (INGN) Cuts Guidance Even As Profitability Climbs
2026-08-17 19:36 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.